Health

The search for Michael Mosley, MD, a British weight-loss doctor and television personality who went missing while vacationing on the island of Symi, has caused growing concern among authorities and the public. The uncertainty surrounding his disappearance raises questions about his safety and well-being. In a worrying development, cows infected with bird flu have been
0 Comments
Central sleep apnea is a serious condition that affects many patients with heart failure, leading to interrupted signals from the brain to the body and causing breathing difficulties during sleep. The use of transvenous phrenic nerve stimulation (TPNS) has been associated with a significant improvement in clinical outcomes for these patients, according to a recent
0 Comments
Recently, a concerning incident occurred where numerous passengers on a flight to Houston fell ill with an unknown illness after returning from an international cruise. This raises questions about the potential spread of infectious diseases through air travel and highlights the importance of stringent health protocols in such situations. Dr. Anthony Fauci, a key figure
0 Comments
A recent interim analysis of the phase III ECHELON-3 trial revealed that a triplet combination of brentuximab vedotin (BV), lenalidomide, and rituximab showed a significant improvement in overall survival for patients with diffuse large B-cell lymphoma (DLBCL). The study, conducted by Jeong-A Kim, MD, at the American Society of Clinical Oncology meeting, demonstrated a 37%
0 Comments
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a challenging condition to diagnose due to its rarity and heterogeneity. Dr. Jeffrey Allen from the University of Minnesota emphasized the critical need for valid biomarkers in CIDP to improve diagnosis and understand disease activity. The current standard treatments for CIDP, including intravenous immunoglobulin (IVIG), steroids, and plasma exchange,
0 Comments
The Food and Drug Administration (FDA) recently issued a warning to Akan Biosciences, a Maryland-based company, regarding their allogenic, adipose-derived stromal vascular fraction (SVF) product, known as Ayama. This warning highlighted the fact that the product must be regulated as a drug and a biologic, as opposed to the more lenient category it was previously
0 Comments